Integrated Drug Discovery Service (IDDS) refers to a comprehensive approach to drug discovery that combines multiple expertise and technologies under one roof, streamlining the entire process from target identification to clinical development. It contrasts with the traditional, more fragmented approach where different stages of drug discovery are often handled by separate companies or research groups.
Market Analysis and Insights: Global Integrated Drug Discovery Service Market
The global Integrated Drug Discovery Service market is projected to grow from US$ 27120 million in 2024 to US$ 57980 million by 2030, at a Compound Annual Growth Rate (CAGR) of 13.5% during the forecast period.
The Integrated Drug Discovery Service market is experiencing strong and sustained growth, fueled by several key factors:
Market Drivers:
Rising demand for new drugs: The global pharmaceutical industry faces constant pressure to develop new and effective drugs for various diseases. Integrated drug discovery services provide a comprehensive solution, streamlining the drug discovery process and accelerating the development of new therapies.
Focus on efficiency and cost-effectiveness: Pharmaceutical companies are looking for ways to reduce the high costs and risks associated with traditional drug discovery. Integrated services offer a more efficient and cost-effective approach by combining various expertise and technologies under one roof.
Technological advancements: Advancements in areas like artificial intelligence, high-throughput screening, and computational biology are transforming the drug discovery landscape, making integrated services even more powerful and efficient.
Growing complexity of drug targets: Modern drug targets are often complex and require a multidisciplinary approach. Integrated services offer access to a wider range of expertise and technologies to tackle these challenges.
Increased outsourcing: Many pharmaceutical companies are choosing to outsource some or all of their drug discovery efforts to specialized CROs (Contract Research Organizations) offering integrated services, allowing them to focus on core competencies and reduce internal resources.
Market Challenges:
High cost of entry: Setting up and maintaining integrated drug discovery capabilities requires significant investment in infrastructure, technology, and personnel, which can be a barrier for smaller players.
Competition: The market is becoming increasingly competitive, with established CROs and emerging startups vying for market share.
Complexities in managing partnerships: Effective collaboration and communication between pharmaceutical companies and integrated service providers are crucial for success, but managing large and complex partnerships can be challenging.
Regulatory hurdles: Stringent regulations in the pharmaceutical industry require strict compliance with quality and safety standards, which can increase the complexity and cost of providing integrated services.
Integration of data and workflows: Integrating data generated from different platforms and technologies within the integrated drug discovery process requires sophisticated data management strategies and expertise.
Overall, the Integrated Drug Discovery Service market is a dynamic and promising sector with significant growth potential. Technological advancements, an increasing focus on efficiency, and the rising demand for new drugs are driving this market forward. However, challenges like managing complex partnerships, navigating regulatory hurdles, and integrating data and workflows need to be addressed to ensure continued success.
Report Covers:
This report presents an overview of global market for Integrated Drug Discovery Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Integrated Drug Discovery Service, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Integrated Drug Discovery Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Integrated Drug Discovery Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Integrated Drug Discovery Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Integrated Drug Discovery Service revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Syngene
Eurofins
Charles River
Evotec
BioAscent
Sygnature Discovery
Jubilant Biosys
Charnwood Molecular
Domainex
Pharmaron
Dalton Pharma Services
Selvita
Metrion Biosciences
WuXi AppTec
Malvern Panalytical
Hitgen
BioDuro
Curia Global
Taros Chemicals
Symeres
Aragen Life Sciences
Segment by Type
Ligand Based Drug Discovery
Structure Based Drug Discovery
Others
Segment by Application
Biotech and Pharmaceutical Companies
Academic Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Integrated Drug Discovery Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Integrated Drug Discovery Service companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Integrated Drug Discovery Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Integrated Drug Discovery Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Ligand Based Drug Discovery
1.2.3 Structure Based Drug Discovery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Integrated Drug Discovery Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Biotech and Pharmaceutical Companies
1.3.3 Academic Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Integrated Drug Discovery Service Market Perspective (2019-2030)
2.2 Global Integrated Drug Discovery Service Growth Trends by Region
2.2.1 Integrated Drug Discovery Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Integrated Drug Discovery Service Historic Market Size by Region (2019-2024)
2.2.3 Integrated Drug Discovery Service Forecasted Market Size by Region (2025-2030)
2.3 Integrated Drug Discovery Service Market Dynamics
2.3.1 Integrated Drug Discovery Service Industry Trends
2.3.2 Integrated Drug Discovery Service Market Drivers
2.3.3 Integrated Drug Discovery Service Market Challenges
2.3.4 Integrated Drug Discovery Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Integrated Drug Discovery Service by Players
3.1.1 Global Integrated Drug Discovery Service Revenue by Players (2019-2024)
3.1.2 Global Integrated Drug Discovery Service Revenue Market Share by Players (2019-2024)
3.2 Global Integrated Drug Discovery Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Integrated Drug Discovery Service, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Integrated Drug Discovery Service Market Concentration Ratio
3.4.1 Global Integrated Drug Discovery Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Integrated Drug Discovery Service Revenue in 2023
3.5 Global Key Players of Integrated Drug Discovery Service Head office and Area Served
3.6 Global Key Players of Integrated Drug Discovery Service, Product and Application
3.7 Global Key Players of Integrated Drug Discovery Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Integrated Drug Discovery Service Breakdown Data by Type
4.1 Global Integrated Drug Discovery Service Historic Market Size by Type (2019-2024)
4.2 Global Integrated Drug Discovery Service Forecasted Market Size by Type (2025-2030)
5 Integrated Drug Discovery Service Breakdown Data by Application
5.1 Global Integrated Drug Discovery Service Historic Market Size by Application (2019-2024)
5.2 Global Integrated Drug Discovery Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Integrated Drug Discovery Service Market Size (2019-2030)
6.2 North America Integrated Drug Discovery Service Market Size by Type
6.2.1 North America Integrated Drug Discovery Service Market Size by Type (2019-2024)
6.2.2 North America Integrated Drug Discovery Service Market Size by Type (2025-2030)
6.2.3 North America Integrated Drug Discovery Service Market Share by Type (2019-2030)
6.3 North America Integrated Drug Discovery Service Market Size by Application
6.3.1 North America Integrated Drug Discovery Service Market Size by Application (2019-2024)
6.3.2 North America Integrated Drug Discovery Service Market Size by Application (2025-2030)
6.3.3 North America Integrated Drug Discovery Service Market Share by Application (2019-2030)
6.4 North America Integrated Drug Discovery Service Market Size by Country
6.4.1 North America Integrated Drug Discovery Service Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Integrated Drug Discovery Service Market Size by Country (2019-2024)
6.4.3 North America Integrated Drug Discovery Service Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Integrated Drug Discovery Service Market Size (2019-2030)
7.2 Europe Integrated Drug Discovery Service Market Size by Type
7.2.1 Europe Integrated Drug Discovery Service Market Size by Type (2019-2024)
7.2.2 Europe Integrated Drug Discovery Service Market Size by Type (2025-2030)
7.2.3 Europe Integrated Drug Discovery Service Market Share by Type (2019-2030)
7.3 Europe Integrated Drug Discovery Service Market Size by Application
7.3.1 Europe Integrated Drug Discovery Service Market Size by Application (2019-2024)
7.3.2 Europe Integrated Drug Discovery Service Market Size by Application (2025-2030)
7.3.3 Europe Integrated Drug Discovery Service Market Share by Application (2019-2030)
7.4 Europe Integrated Drug Discovery Service Market Size by Country
7.4.1 Europe Integrated Drug Discovery Service Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Integrated Drug Discovery Service Market Size by Country (2019-2024)
7.4.3 Europe Integrated Drug Discovery Service Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Integrated Drug Discovery Service Market Size (2019-2030)
8.2 China Integrated Drug Discovery Service Market Size by Type
8.2.1 China Integrated Drug Discovery Service Market Size by Type (2019-2024)
8.2.2 China Integrated Drug Discovery Service Market Size by Type (2025-2030)
8.2.3 China Integrated Drug Discovery Service Market Share by Type (2019-2030)
8.3 China Integrated Drug Discovery Service Market Size by Application
8.3.1 China Integrated Drug Discovery Service Market Size by Application (2019-2024)
8.3.2 China Integrated Drug Discovery Service Market Size by Application (2025-2030)
8.3.3 China Integrated Drug Discovery Service Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Integrated Drug Discovery Service Market Size (2019-2030)
9.2 Asia Integrated Drug Discovery Service Market Size by Type
9.2.1 Asia Integrated Drug Discovery Service Market Size by Type (2019-2024)
9.2.2 Asia Integrated Drug Discovery Service Market Size by Type (2025-2030)
9.2.3 Asia Integrated Drug Discovery Service Market Share by Type (2019-2030)
9.3 Asia Integrated Drug Discovery Service Market Size by Application
9.3.1 Asia Integrated Drug Discovery Service Market Size by Application (2019-2024)
9.3.2 Asia Integrated Drug Discovery Service Market Size by Application (2025-2030)
9.3.3 Asia Integrated Drug Discovery Service Market Share by Application (2019-2030)
9.4 Asia Integrated Drug Discovery Service Market Size by Region
9.4.1 Asia Integrated Drug Discovery Service Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Integrated Drug Discovery Service Market Size by Region (2019-2024)
9.4.3 Asia Integrated Drug Discovery Service Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Type
10.2.1 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Application
10.3.1 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Country
10.4.1 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Integrated Drug Discovery Service Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Syngene
11.1.1 Syngene Company Details
11.1.2 Syngene Business Overview
11.1.3 Syngene Integrated Drug Discovery Service Introduction
11.1.4 Syngene Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.1.5 Syngene Recent Developments
11.2 Eurofins
11.2.1 Eurofins Company Details
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Integrated Drug Discovery Service Introduction
11.2.4 Eurofins Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.2.5 Eurofins Recent Developments
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Integrated Drug Discovery Service Introduction
11.3.4 Charles River Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.3.5 Charles River Recent Developments
11.4 Evotec
11.4.1 Evotec Company Details
11.4.2 Evotec Business Overview
11.4.3 Evotec Integrated Drug Discovery Service Introduction
11.4.4 Evotec Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.4.5 Evotec Recent Developments
11.5 BioAscent
11.5.1 BioAscent Company Details
11.5.2 BioAscent Business Overview
11.5.3 BioAscent Integrated Drug Discovery Service Introduction
11.5.4 BioAscent Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.5.5 BioAscent Recent Developments
11.6 Sygnature Discovery
11.6.1 Sygnature Discovery Company Details
11.6.2 Sygnature Discovery Business Overview
11.6.3 Sygnature Discovery Integrated Drug Discovery Service Introduction
11.6.4 Sygnature Discovery Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.6.5 Sygnature Discovery Recent Developments
11.7 Jubilant Biosys
11.7.1 Jubilant Biosys Company Details
11.7.2 Jubilant Biosys Business Overview
11.7.3 Jubilant Biosys Integrated Drug Discovery Service Introduction
11.7.4 Jubilant Biosys Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.7.5 Jubilant Biosys Recent Developments
11.8 Charnwood Molecular
11.8.1 Charnwood Molecular Company Details
11.8.2 Charnwood Molecular Business Overview
11.8.3 Charnwood Molecular Integrated Drug Discovery Service Introduction
11.8.4 Charnwood Molecular Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.8.5 Charnwood Molecular Recent Developments
11.9 Domainex
11.9.1 Domainex Company Details
11.9.2 Domainex Business Overview
11.9.3 Domainex Integrated Drug Discovery Service Introduction
11.9.4 Domainex Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.9.5 Domainex Recent Developments
11.10 Pharmaron
11.10.1 Pharmaron Company Details
11.10.2 Pharmaron Business Overview
11.10.3 Pharmaron Integrated Drug Discovery Service Introduction
11.10.4 Pharmaron Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.10.5 Pharmaron Recent Developments
11.11 Dalton Pharma Services
11.11.1 Dalton Pharma Services Company Details
11.11.2 Dalton Pharma Services Business Overview
11.11.3 Dalton Pharma Services Integrated Drug Discovery Service Introduction
11.11.4 Dalton Pharma Services Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.11.5 Dalton Pharma Services Recent Developments
11.12 Selvita
11.12.1 Selvita Company Details
11.12.2 Selvita Business Overview
11.12.3 Selvita Integrated Drug Discovery Service Introduction
11.12.4 Selvita Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.12.5 Selvita Recent Developments
11.13 Metrion Biosciences
11.13.1 Metrion Biosciences Company Details
11.13.2 Metrion Biosciences Business Overview
11.13.3 Metrion Biosciences Integrated Drug Discovery Service Introduction
11.13.4 Metrion Biosciences Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.13.5 Metrion Biosciences Recent Developments
11.14 WuXi AppTec
11.14.1 WuXi AppTec Company Details
11.14.2 WuXi AppTec Business Overview
11.14.3 WuXi AppTec Integrated Drug Discovery Service Introduction
11.14.4 WuXi AppTec Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.14.5 WuXi AppTec Recent Developments
11.15 Malvern Panalytical
11.15.1 Malvern Panalytical Company Details
11.15.2 Malvern Panalytical Business Overview
11.15.3 Malvern Panalytical Integrated Drug Discovery Service Introduction
11.15.4 Malvern Panalytical Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.15.5 Malvern Panalytical Recent Developments
11.16 Hitgen
11.16.1 Hitgen Company Details
11.16.2 Hitgen Business Overview
11.16.3 Hitgen Integrated Drug Discovery Service Introduction
11.16.4 Hitgen Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.16.5 Hitgen Recent Developments
11.17 BioDuro
11.17.1 BioDuro Company Details
11.17.2 BioDuro Business Overview
11.17.3 BioDuro Integrated Drug Discovery Service Introduction
11.17.4 BioDuro Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.17.5 BioDuro Recent Developments
11.18 Curia Global
11.18.1 Curia Global Company Details
11.18.2 Curia Global Business Overview
11.18.3 Curia Global Integrated Drug Discovery Service Introduction
11.18.4 Curia Global Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.18.5 Curia Global Recent Developments
11.19 Taros Chemicals
11.19.1 Taros Chemicals Company Details
11.19.2 Taros Chemicals Business Overview
11.19.3 Taros Chemicals Integrated Drug Discovery Service Introduction
11.19.4 Taros Chemicals Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.19.5 Taros Chemicals Recent Developments
11.20 Symeres
11.20.1 Symeres Company Details
11.20.2 Symeres Business Overview
11.20.3 Symeres Integrated Drug Discovery Service Introduction
11.20.4 Symeres Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.20.5 Symeres Recent Developments
11.21 Aragen Life Sciences
11.21.1 Aragen Life Sciences Company Details
11.21.2 Aragen Life Sciences Business Overview
11.21.3 Aragen Life Sciences Integrated Drug Discovery Service Introduction
11.21.4 Aragen Life Sciences Revenue in Integrated Drug Discovery Service Business (2019-2024)
11.21.5 Aragen Life Sciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Syngene
Eurofins
Charles River
Evotec
BioAscent
Sygnature Discovery
Jubilant Biosys
Charnwood Molecular
Domainex
Pharmaron
Dalton Pharma Services
Selvita
Metrion Biosciences
WuXi AppTec
Malvern Panalytical
Hitgen
BioDuro
Curia Global
Taros Chemicals
Symeres
Aragen Life Sciences
听
听
*If Applicable.
